AIM ImmunoTech (AIM) News Today $0.22 -0.03 (-11.86%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period AIM ImmunoTech Inc. (AMEX:AIM) Q3 2024 Earnings Call TranscriptNovember 16 at 1:08 PM | msn.comAIM Down on Q3 ResultsNovember 16 at 3:05 AM | baystreet.caAIM ImmunoTech files to sell 9.31M shares of common stock for holdersNovember 16 at 3:05 AM | markets.businessinsider.comAIM ImmunoTech Inc (AIM) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...November 16 at 3:05 AM | finance.yahoo.comAIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call TranscriptNovember 15 at 11:06 AM | seekingalpha.comAIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 15 at 7:29 AM | globenewswire.comKellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card Now for Desperately Needed Change to the AIM BoardNovember 14 at 11:29 AM | finance.yahoo.comInsights into AIM ImmunoTech's Upcoming EarningsNovember 14 at 11:29 AM | benzinga.comExploring AIM ImmunoTech's Earnings ExpectationsNovember 7, 2024 | benzinga.comAIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and WebcastNovember 6, 2024 | globenewswire.comAIM ImmunoTech price target lowered to $1 from $2 at MaximOctober 23, 2024 | markets.businessinsider.comAIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLCOctober 9, 2024 | markets.businessinsider.comAIM ImmunoTech (AMEX:AIM) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comAIM ImmunoTech (AMEX:AIM) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comAIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of EndometriosisOctober 3, 2024 | globenewswire.comAIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct OfferingSeptember 30, 2024 | finance.yahoo.comAIM ImmunoTech to Participate in Virtual Investor CEO Connect SegmentSeptember 27, 2024 | globenewswire.comAIM Reports Positive Preliminary Data From Phase 1b/2 Study Of Ampligen, Imfinzi As CombinationSeptember 19, 2024 | markets.businessinsider.comAIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer ResearchAugust 20, 2024 | globenewswire.comAIM ImmunoTech Inc. (AMEX:AIM) Q2 2024 Earnings Call TranscriptAugust 17, 2024 | msn.comAIM ImmunoTech Inc.: AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 16, 2024 | finanznachrichten.deAIM ImmunoTech Inc. (AIM) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | seekingalpha.comAIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 16, 2024 | globenewswire.comSamson Rock Capital LLP - Form 8.3 - Trident Royalties PlcAugust 13, 2024 | uk.finance.yahoo.comJim Click's 2006 Ford Mustang FR500C Race Car Hits Bring a Trailer AuctionAugust 13, 2024 | msn.com535p?! This broker just hiked the forecast for the Rolls-Royce share priceAugust 13, 2024 | msn.comAIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Conference Call and WebcastAugust 13, 2024 | globenewswire.comAIM ImmunoTech Announces Release of the Next CEO Corner SegmentJuly 29, 2024 | globenewswire.comAIM Announces New Positive Data on Ampligen’s Anti-Tumor Potential When Used as Part of a Combination TherapyJuly 25, 2024 | finance.yahoo.comAIM Announces New Positive Data on Ampligen's Anti-Tumor Potential When Used as Part of a Combination TherapyJuly 24, 2024 | globenewswire.comAIM ImmunoTech Announces Release of the Next CEO Corner SegmentJuly 3, 2024 | globenewswire.comAIM ImmunoTech to Participate in the Virtual Investor Pitch ConferenceJune 10, 2024 | globenewswire.comAIM ImmunoTech to Participate in the Virtual Investor Lunch Break SeriesJune 3, 2024 | globenewswire.comAIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct OfferingMay 31, 2024 | globenewswire.comAIM ImmunoTech to Participate in Two Upcoming Investor ConferencesMay 20, 2024 | globenewswire.comBuy Rating Affirmed: AIM ImmunoTech’s Ampligen Shows Promising Oncology Pipeline ProgressMay 17, 2024 | markets.businessinsider.comQ1 2024 AIM ImmunoTech Inc Earnings CallMay 17, 2024 | finance.yahoo.comAIM ImmunoTech Inc. (AMEX:AIM) Q1 2024 Earnings Call TranscriptMay 17, 2024 | msn.comAIM ImmunoTech Inc.: AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 16, 2024 | finanznachrichten.deAIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024May 16, 2024 | investorplace.comAIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 16, 2024 | globenewswire.comAIM ImmunoTech Q1 2024 Earnings PreviewMay 15, 2024 | msn.comAIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and WebcastMay 9, 2024 | globenewswire.comAIM ImmunoTech Inc. (NYSE:AIM) COO Peter W. Rodino III Buys 30,865 SharesMay 8, 2024 | insidertrades.comAIM ImmunoTech Inc.: AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®May 6, 2024 | finanznachrichten.deAIM Completes Ampligen TurnoutMay 6, 2024 | baystreet.caAIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®May 6, 2024 | globenewswire.comAIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic CancerApril 29, 2024 | globenewswire.comAIM ImmunoTech Announces Release of the Next CEO Corner SegmentApril 25, 2024 | globenewswire.comAIM ImmunoTech Inc.: AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID ProgramsApril 15, 2024 | finanznachrichten.de Get AIM ImmunoTech News Delivered to You Automatically Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. AIM Media Mentions By Week AIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AIM News Sentiment▼0.410.56▲Average Medical News Sentiment AIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AIM Articles This Week▼81▲AIM Articles Average Week Get AIM ImmunoTech News Delivered to You Automatically Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IOBT News RAPT News STTK News MURA News ENTX News THTX News CNTB News ATRA News AFMD News ALGS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AIM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
